Ilika plc Grant of Fuel Cell Catalyst Patents in USA

Ilika plc

Ilika plc (LON:IKA), a pioneer in solid-state battery technology and materials innovation, announced today the grant of three patents covering catalysts for hydrogen fuel cells in the USA. These patents cover a type of catalyst known as “Core-Shell Catalysts”, where the catalyst is the coating on nano-scale spherical particles, like the hard shell on a golf ball.

Catalysts are key to ensuring the efficiency and reliability of fuel cells. The catalysts must therefore be stable in the aggressive acidic environment created within hydrogen fuel cells, whilst highly active in promoting the chemical reactions necessary for converting hydrogen and oxygen into electricity and water.

Core-Shell Nanostructured Catalysts typically have a relatively low-cost and stable core, which is then coated with a thin layer (shell) of the active catalyst. The Company’s patented catalysts have mixed metal oxide (ceramic) cores covered in platinum. The three wholly owned granted patents were originally filed in January 2013. The Company had previously undertaken a joint development project with Toyota examining other catalyst materials which resulted in an earlier jointly-owned patent filing, which has since gone to grant in Japan and is currently being processed in other jurisdictions.

Commenting on the patents granted, Graeme Purdy, Ilika Plc CEO, said: “Whilst our solid-state battery programme is our key focus, our materials discovery platform is generating innovative, patentable materials with a variety of applications. The pace of innovation in the automotive industry has never been greater as companies compete to develop increasingly more energy-efficient, low emission vehicles. While electrical hybrid vehicles using battery technology have captured the largest share of the low-emission market at this point and fully battery-powered electric vehicles are also seeing strong take-up, fuel cell vehicles offer the advantage of long driving range, which justifies the development of key technologies such as low-cost, robust catalysts.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search